News Focus
News Focus
icon url

DewDiligence

10/15/20 10:36 AM

#235127 RE: DrContango #233669

VRTX -19% on discontinuation of AATD program due to liver toxicity:

https://finance.yahoo.com/news/vertex-provides-clinical-programs-targeting-203000654.html